{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:37:47Z","timestamp":1787002667530,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A previous study of 200,000 exome-sequenced UK Biobank participants investigating the association between rare coding variants and hyperlipidaemia had implicated four genes,\n                    <jats:italic>LDLR<\/jats:italic>\n                    ,\n                    <jats:italic>PCSK9<\/jats:italic>\n                    ,\n                    <jats:italic>APOC3<\/jats:italic>\n                    and\n                    <jats:italic>IFITM5<\/jats:italic>\n                    , at exome-wide significance. In addition, a further 43 protein-coding genes were significant with an uncorrected\n                    <jats:italic>p<\/jats:italic>\n                    value of &lt;0.001. Exome sequence data has become available for a further 270,000 participants and weighted burden analysis to test for association with hyperlipidaemia was carried out in this sample for the 47 genes highlighted by the previous study. There was no evidence to implicate\n                    <jats:italic>IFITM5<\/jats:italic>\n                    but\n                    <jats:italic>LDLR<\/jats:italic>\n                    ,\n                    <jats:italic>PCSK9<\/jats:italic>\n                    ,\n                    <jats:italic>APOC3<\/jats:italic>\n                    ,\n                    <jats:italic>ANGPTL3<\/jats:italic>\n                    ,\n                    <jats:italic>ABCG5<\/jats:italic>\n                    and\n                    <jats:italic>NPC1L1<\/jats:italic>\n                    were all statistically significant after correction for multiple testing. These six genes were also all exome-wide significant in the combined sample of 470,000 participants. Variants impairing function of\n                    <jats:italic>LDLR<\/jats:italic>\n                    and\n                    <jats:italic>ABCG5<\/jats:italic>\n                    were associated with increased risk whereas variants in the other genes were protective. Variant categories associated with large effect sizes are cumulatively very rare and the main benefit of this kind of study seems to be to throw light on the molecular mechanisms impacting hyperlipidaemia risk, hopefully supporting attempts to develop improved therapies.\n                  <\/jats:p>","DOI":"10.1038\/s10038-024-01235-8","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T01:01:52Z","timestamp":1709773312000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Weighted burden analysis of rare coding variants in 470,000 exome-sequenced UK Biobank participants characterises effects on hyperlipidaemia risk"],"prefix":"10.1038","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4089-9183","authenticated-orcid":false,"given":"David","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"1235_CR1","doi-asserted-by":"crossref","unstructured":"Curtis D. Analysis of 200 000 exome-sequenced UK Biobank subjects illustrates the contribution of rare genetic variants to hyperlipidaemia. J Med Genet. 2021. Available from: https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2021-107752.","DOI":"10.1101\/2021.01.05.20249090"},{"key":"1235_CR2","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dhindsa RS, Carss K, Harper AR, Nag A, Tachmazidou I, et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021;597:7877. https:\/\/www.nature.com\/articles\/s41586-021-03855-y.","journal-title":"Nature"},{"key":"1235_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman JD, Li AH, Marcketta A, Sun D, Mbatchou J, Kessler MD, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599:628\u201334. https:\/\/pubmed.ncbi.nlm.nih.gov\/34662886\/.","journal-title":"Nature"},{"key":"1235_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122. http:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"key":"1235_CR5","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;7. Unit7.20. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23315928.","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"1235_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073\u201381. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19561590.","journal-title":"Nat Protoc"},{"key":"1235_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7 https:\/\/academic.oup.com\/gigascience\/article-lookup\/doi\/10.1186\/s13742-015-0047-8.","journal-title":"Gigascience"},{"key":"1235_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajhg.2015.12.022","volume":"98","author":"KJ Galinsky","year":"2016","unstructured":"Galinsky KJ, Bhatia G, Loh PR, Georgiev S, Mukherjee S, Patterson NJ, et al. Fast Principal-Component Analysis Reveals Convergent Evolution of ADH1B in Europe and East Asia. Am J Hum Genet. 2016;98:456\u201372. https:\/\/pubmed.ncbi.nlm.nih.gov\/26924531\/.","journal-title":"Am J Hum Genet"},{"key":"1235_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ymgme.2020.07.009","volume":"131","author":"D Curtis","year":"2020","unstructured":"Curtis D. Analysis of exome-sequenced UK Biobank subjects implicates genes affecting risk of hyperlipidaemia. Mol Genet Metab. 2020;131:277\u201383. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301785.","journal-title":"Mol Genet Metab"},{"key":"1235_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/30305743\/.","journal-title":"Nature"},{"key":"1235_CR11","first-page":"1","volume":"5","author":"D Curtis","year":"2012","unstructured":"Curtis D. A rapid method for combined analysis of common and rare variants at the level of a region, gene, or pathway. Adv Appl Bioinform Chem. 2012;5:1\u20139.","journal-title":"Adv Appl Bioinform Chem"},{"key":"1235_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/YPG.0000000000000132","volume":"26","author":"D Curtis","year":"2016","unstructured":"Curtis D. Pathway analysis of whole exome sequence data provides further support for the involvement of histone modification in the aetiology of schizophrenia. Psychiatr Genet. 2016;26:223\u20137. http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00041444-900000000-99634.","journal-title":"Psychiatr Genet"},{"key":"1235_CR13","doi-asserted-by":"crossref","unstructured":"Curtis D. Multiple Linear Regression Allows Weighted Burden Analysis of Rare Coding Variants in an Ethnically Heterogeneous Population. Hum Hered. 2020;1\u201310. Available from: https:\/\/www.karger.com\/Article\/FullText\/512576.","DOI":"10.1159\/000512576"},{"key":"1235_CR14","unstructured":"R Core Team. R: A language and environment for statistical computing. [Internet]. Vienna, Austria.: R Foundation for Statistical Computing; 2014. Available from: http:\/\/www.r-project.org."},{"key":"1235_CR15","first-page":"443","volume":"49","author":"V Meiner","year":"1991","unstructured":"Meiner V, Landsberger D, Berkman N, Reshef A, Segal P, Seftel HC, et al. A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am J Hum Genet. 1991;49:443.","journal-title":"Am J Hum Genet"},{"key":"1235_CR16","doi-asserted-by":"publisher","first-page":"e1005379","DOI":"10.1371\/journal.pgen.1005379","volume":"11","author":"S Gretarsdottir","year":"2015","unstructured":"Gretarsdottir S, Helgason H, Helgadottir A, Sigurdsson A, Thorleifsson G, Magnusdottir A, et al. A Splice Region Variant in LDLR Lowers Non-high Density Lipoprotein Cholesterol and Protects against Coronary Artery Disease. PLoS Genet. 2015;11:e1005379. https:\/\/pubmed.ncbi.nlm.nih.gov\/26327206\/.","journal-title":"PLoS Genet"},{"key":"1235_CR17","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehaa531","volume":"41","author":"A Helgadottir","year":"2020","unstructured":"Helgadottir A, Thorleifsson G, Alexandersson KF, Tragante V, Thorsteinsdottir M, Eiriksson FF, et al. Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease. Eur Heart J. 2020;41:2618\u201328. https:\/\/pubmed.ncbi.nlm.nih.gov\/32702746\/.","journal-title":"Eur Heart J"},{"key":"1235_CR18","first-page":"755","volume":"4","author":"X Wang","year":"2019","unstructured":"Wang X, Musunuru K. Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing. JACC: Basic Transl Sci. 2019;4:755\u201362.","journal-title":"JACC: Basic Transl Sci"},{"key":"1235_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s40142-016-0097-y","volume":"4","author":"JS Dron","year":"2016","unstructured":"Dron JS, Hegele RA. Genetics of Lipid and Lipoprotein Disorders and Traits. Curr Genet Med Rep. 2016;4:130\u201341.","journal-title":"Curr Genet Med Rep"},{"key":"1235_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ng.3561","volume":"48","author":"A Helgadottir","year":"2016","unstructured":"Helgadottir A, Gretarsdottir S, Thorleifsson G, Hjartarson E, Sigurdsson A, Magnusdottir A, et al. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet. 2016;48:634\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/27135400\/.","journal-title":"Nat Genet"},{"key":"1235_CR21","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.febslet.2010.03.030","volume":"584","author":"JL Betters","year":"2010","unstructured":"Betters JL, Yu L. NPC1L1 and cholesterol transport. FEBS Lett. 2010;584:2740\u20137.","journal-title":"FEBS Lett"},{"key":"1235_CR22","unstructured":"Doggrell SA. Will evinacumab become the standard treatment for homozygous familial hypercholesterolemia? Expert Opin Biol Ther. 2020;1\u20134. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2021.1862083."},{"key":"1235_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11883-022-01076-w","volume":"25","author":"S Bini","year":"2023","unstructured":"Bini S, Tramontano D, Minicocci I, Di Costanzo A, Tambaro F, D\u2019Erasmo L, et al. How ANGPTL3 Inhibition Will Help Our Clinical Practice? Curr Atheroscler Rep. 2023;25:19\u201329. https:\/\/pubmed.ncbi.nlm.nih.gov\/36607583\/.","journal-title":"Curr Atheroscler Rep"},{"key":"1235_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11883-019-0791-9","volume":"21","author":"MR Taskinen","year":"2019","unstructured":"Taskinen MR, Packard CJ, Bor\u00e9n J. Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD. Curr Atheroscler Rep. 2019;21:27. https:\/\/pubmed.ncbi.nlm.nih.gov\/31111320\/.","journal-title":"Curr Atheroscler Rep"},{"key":"1235_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/molecules27020434","volume":"27","author":"N Kuzmich","year":"2022","unstructured":"Kuzmich N, Andresyuk E, Porozov Y, Tarasov V, Samsonov M, Preferanskaya N, et al. PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs. Molecules. 2022;27:434. https:\/\/pubmed.ncbi.nlm.nih.gov\/35056760\/.","journal-title":"Molecules"},{"key":"1235_CR26","doi-asserted-by":"publisher","first-page":"146039","DOI":"10.1016\/j.gene.2021.146039","volume":"809","author":"D Curtis","year":"2022","unstructured":"Curtis D. Exploration of weighting schemes based on allele frequency and annotation for weighted burden association analysis of complex phenotypes. Gene. 2022;809:146039. https:\/\/pubmed.ncbi.nlm.nih.gov\/34688815\/.","journal-title":"Gene"},{"key":"1235_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes11090987","volume":"11","author":"S Amanat","year":"2020","unstructured":"Amanat S, Requena T, Lopez-Escamez JA. A Systematic Review of Extreme Phenotype Strategies to Search for Rare Variants in Genetic Studies of Complex Disorders. Genes. 2020;11:1\u201315. https:\/\/pubmed.ncbi.nlm.nih.gov\/32854191\/.","journal-title":"Genes"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-024-01235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-024-01235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-024-01235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T19:03:13Z","timestamp":1716577393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-024-01235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1038\/s10038-024-01235-8","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}